These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 32822087)

  • 41. Enteric Glia at the Crossroads between Intestinal Immune System and Epithelial Barrier: Implications for Parkinson Disease.
    Benvenuti L; D'Antongiovanni V; Pellegrini C; Antonioli L; Bernardini N; Blandizzi C; Fornai M
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276665
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-CNS pathogenic origin of Parkinson's disease.
    Choudhry H; Perlmuter LC
    J Neurol; 2017 Sep; 264(9):2027-2030. PubMed ID: 28808780
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lipopolysaccharide from Gut Microbiota Modulates α-Synuclein Aggregation and Alters Its Biological Function.
    Bhattacharyya D; Mohite GM; Krishnamoorthy J; Gayen N; Mehra S; Navalkar A; Kotler SA; Ratha BN; Ghosh A; Kumar R; Garai K; Mandal AK; Maji SK; Bhunia A
    ACS Chem Neurosci; 2019 May; 10(5):2229-2236. PubMed ID: 30855940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Neuropathology and pathophysiology of Parkinson's disease: Focus on α-synuclein].
    Prigent A; Lionnet A; Corbillé AG; Derkinderen P
    Presse Med; 2017 Mar; 46(2 Pt 1):182-186. PubMed ID: 28040347
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gut-Brain axis in Parkinson's disease etiology: The role of lipopolysaccharide.
    Bhattacharyya D; Bhunia A
    Chem Phys Lipids; 2021 Mar; 235():105029. PubMed ID: 33338469
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gut bacterial composition in a mouse model of Parkinson's disease.
    Perez-Pardo P; Dodiya HB; Engen PA; Naqib A; Forsyth CB; Green SJ; Garssen J; Keshavarzian A; Kraneveld AD
    Benef Microbes; 2018 Sep; 9(5):799-814. PubMed ID: 30099890
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Review: The Role of Intestinal Dysbiosis in Parkinson's Disease.
    Huang Y; Liao J; Liu X; Zhong Y; Cai X; Long L
    Front Cell Infect Microbiol; 2021; 11():615075. PubMed ID: 33968794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The gut-brain connection in the pathogenicity of Parkinson disease: Putative role of autophagy.
    Kakoty V; K C S; Dubey SK; Yang CH; Kesharwani P; Taliyan R
    Neurosci Lett; 2021 May; 753():135865. PubMed ID: 33812929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does Parkinson's disease start in the gut?
    Gershanik OS
    Arq Neuropsiquiatr; 2018 Feb; 76(2):67-70. PubMed ID: 29489958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of the Gut Microbiome and Bacterial Amyloids in the Development of Synucleinopathies.
    Trubitsina NP; Matiiv AB; Rogoza TM; Zudilova AA; Bezgina MD; Zhouravleva GA; Bondarev SA
    Biochemistry (Mosc); 2024 Mar; 89(3):523-542. PubMed ID: 38648770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A neuroscience perspective of the gut theory of Parkinson's disease.
    Smith LM; Parr-Brownlie LC
    Eur J Neurosci; 2019 Mar; 49(6):817-823. PubMed ID: 29446158
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bile acid abnormality induced by intestinal dysbiosis might explain lipid metabolism in Parkinson's disease.
    Hasuike Y; Endo T; Koroyasu M; Matsui M; Mori C; Yamadera M; Fujimura H; Sakoda S
    Med Hypotheses; 2020 Jan; 134():109436. PubMed ID: 31678900
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Colonic bacterial composition in Parkinson's disease.
    Keshavarzian A; Green SJ; Engen PA; Voigt RM; Naqib A; Forsyth CB; Mutlu E; Shannon KM
    Mov Disord; 2015 Sep; 30(10):1351-60. PubMed ID: 26179554
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
    Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
    Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lots of Movement in Gut and Parkinson's Research.
    Mercado G; Brundin P
    Trends Endocrinol Metab; 2019 Oct; 30(10):687-689. PubMed ID: 31473011
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The relation between α-synuclein and microglia in Parkinson's disease: Recent developments.
    Sanchez-Guajardo V; Tentillier N; Romero-Ramos M
    Neuroscience; 2015 Aug; 302():47-58. PubMed ID: 25684748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Role of The Gut Microbiome in Parkinson's Disease.
    Gallop A; Weagley J; Paracha SU; Grossberg G
    J Geriatr Psychiatry Neurol; 2021 Jul; 34(4):253-262. PubMed ID: 34219519
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Parkinson's disease; the hibernating spore hypothesis.
    Berstad K; Berstad JER
    Med Hypotheses; 2017 Jul; 104():48-53. PubMed ID: 28673590
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gut dysfunction in Parkinson's disease.
    Mukherjee A; Biswas A; Das SK
    World J Gastroenterol; 2016 Jul; 22(25):5742-52. PubMed ID: 27433087
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
    Campos-Acuña J; Elgueta D; Pacheco R
    Front Immunol; 2019; 10():239. PubMed ID: 30828335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.